Molecular Analysis of Insulin Action Using High Throughput Genetic Screens

Total Page:16

File Type:pdf, Size:1020Kb

Molecular Analysis of Insulin Action Using High Throughput Genetic Screens Molecular analysis of insulin action using high throughput genetic screens Poh Sim Khoo Thesis submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Garvan Institute of Medical Research University of New South Wales 31st March 2011 PLEASE TYPE THE UNIVERSITY OF NEW SOUTH WALES Thesis/Dissertation Sheet Surname or Family name: Khoo First name: Poh Sim Other name/s: Abbreviation for degree as given in the University calendar: PhD School: St Vincent's Cllinical School Faculty:Medicine Title: Molecular analysis of insulin action using high throughput genetic screens Abstract 350 words maximum: (PLEASE TYPE) The insulin-stimulated uptake of glucose by muscle and adipose is vital for the maintenance of glucose homeostasis in the body. This uptake primarily occurs through the action of the insulin-regulatable glucose transporter GLUT4, which is rapidly translocated to the plasma membrane in response to the insulin signal. However, in the insulin resistant state, insulin is unable to effect a normal biological response in its target tissues, characterized by decreased glucose uptake as a result of defects in insulin signaling and attenuated GLUT4 translocation. Elucidating the molecular causes underlying insulin resistance is important for the development of therapeutics for this disease. Identifying the components involved in the propagation or regulation of insulin signaling is an important step in understanding insulin resistance. To date, the upstream components of the signaling pathway are well established, demonstrating the importance of the insulin receptor, IRS proteins and PI3K/Akt signaling axis in this process. As a result much work has focused on defects at the point of IRS in the development of insulin resistance. However, it has recently been suggested that defects associated with insulin resistance occur independently of IRS. Therefore, identifying the sites that this dysfunction occurs at is of great interest in understanding this disease. The purpose of this study is to discover novel proteins involved in the regulation of the insulin signaling and GLUT4 translocation. A GLUT4-overexpressing HeLa cell line was developed and optimized for use in high throughput screening for regulators of insulin stimulated GLUT4 translocation. Insulin stimulation caused GLUT4 translocation to the plasma membrane, and the activation of the PI3K/Akt signaling pathway in these cells. Using this cell line, I performed an siRNA screen of kinase and DUB libraries which identified a number of novel targets that may play a role in the regulation of insulin stimulated GLUT4 translocation. In conclusion, this assay can be used to identify novel regulators of insulin stimulated GLUT4 translocation, which may potentially represent targets for drug development in the treatment of insulin resistance Declaration relating to disposition of project thesis/dissertation I hereby grant to the University of New South Wales or its agents the right to archive and to make available my thesis or dissertation in whole or in part in the University libraries in all forms of media, now or here after known, subject to the provisions of the Copyright Act 1968. I retain all property rights, such as patent rights. I also retain the right to use in future works (such as articles or books) all or part of this thesis or dissertation. I also authorise University Microfilms to use the 350 word abstract of my thesis in Dissertation Abstracts International (this is applicable to doctoral theses only). .... .... Signature Witness Date The University recognises that there may be exceptional circumstances requiring restrictions on copying or conditions on use. Requests for restriction for a period of up to 2 years must be made in writing. Requests for a longer period of restriction may be considered in exceptional circumstances and require the approval of the Dean of Graduate Research. FOR OFFICE USE ONLY Date of completion of requirements for Award: THIS SHEET IS TO BE GLUED TO THE INSIDE FRONT COVER OF THE THESIS ORIGINALITY STATEMENT ‘I hereby declare that this submission is my own work and to the best of my knowledge it contains no materials previously published or written by another person, or substantial proportions of material which have been accepted for the award of any other degree or diploma at UNSW or any other educational institution, except where due acknowledgement is made in the thesis. Any contribution made to the research by others, with whom I have worked at UNSW or elsewhere, is explicitly acknowledged in the thesis. I also declare that the intellectual content of this thesis is the product of my own work, except to the extent that assistance from others in the project's design and conception or in style, presentation and linguistic expression is acknowledged.’ Signed ................................................................. Date ................................................................. Acknowledgements I would like to thank my supervisor at the Garvan, David James. I feel privileged to have been able to work on a challenging project, and it would not have been possible without his vision and guidance. I would also like to thank my co-supervisor Jackie Stoeckli for her great practical advice and for teaching me techniques in the lab that I have used during my PhD. At Genentech, I would like to thank Richard Scheller for the opportunity to work in his lab. Thanks to my supervisor Jagath Junutula, I am extremely grateful for his help, advice and enthusiasm. I would also like to thank my colleagues in the lab; Karen Ervin, Sunil Bhakta, Siler Panowski and Coen Kuijl for the friendship and laughter, and for making it a great environment to be in. Thanks to James Lee for his work with the optimization and execution of the siRNA transfections, Jean-Philippe Stephan for all of his help with running the screens and the image analysis and Eric Torres for his help with the data analysis. Their help with the siRNA screens was invaluable. Finally thanks to my friends and family for believing in me and supporting me through this time, it is very much appreciated. Table of Contents Summary 1 Chapter 1 – General Introduction 3 Insulin and the maintenance of glucose homeostasis 4 The GLUT4 glucose transporter 4 Insulin-stimulated GLUT4 translocation 6 PI3K-dependent insulin signaling 6 PI3K 7 Akt 7 AS160 8 aPKC (λ, ζ) 9 PI3K-independent signaling 10 Contraction stimulated GLUT4 translocation 12 Increased intracellular calcium 12 AMPK 13 Convergence of insulin and contraction signaling pathways leading to GLUT4 translocation 14 Insulin resistance 15 Inflammation and insulin resistance 16 JNK 16 IKKβ 16 ERK 17 P62 signaling adaptor 17 SOCs proteins 18 GSK3 18 PKCθ 19 Tyrosine and serine phosphatases 19 PIKfyve 20 Hypothesis and aims 21 Chapter 2 – Materials and Methods 22 Reagents, Antibodies and Constructs 23 Cell Culture and Transfections 23 Generation of HeLa cells stably expressing HA-GLUT4 24 siRNA Transfection (screening) 24 Quantitative GLUT4 translocation assay 24 IN Cell image acquisition 25 Image analysis 25 Transferrin uptake assay 25 Immunofluorescence microscopy 26 Taqman analysis for gene knockdown 26 Preparation of cell lysates 27 Western blotting 27 Chapter 3 – Development of a GLUT4 translocation assay in HeLa cells 29 Introduction 30 Results 34 HeLa cells stably expressing HA-GLUT4 exhibit insulin stimulated GLUT4 translocation 34 HA-GLUT4-HeLa cells express the majority of genes expressed in human adipose and muscle tissue 34 Localization of GLUT4 in the HA-GLUT4-HeLa cell line 37 Insulin, IGF1 and EGF treatment of HA-GLUT4-HeLa cells induces GLUT4 translocation 39 Comparison of insulin signaling in HA-GLUT4-HeLa cells and 3T3-L1 adipocytes 40 PI3K and Akt inhibitors block insulin-stimulated GLUT4 translocation in both 3T3-L1 adipocytes and HA-GLUT4-HeLa cells 41 siRNA-mediated knockdown of Akt and PI3K inhibits GLUT4 translocation in HA-GLUT4-HeLa cells 41 Development of GLUT4 translocation assay for high throughput screening using the HA-GLUT4-HeLa cell line 43 Discussion 47 Chapter 4 – Identifying kinase regulators of insulin signaling and GLUT4 translocation by siRNA screening 51 Introduction 52 The insulin receptor – kinase activity and regulation by phosphorylation 52 Phosphorylation of IRS proteins and modulation of the insulin signal 53 Kinase regulation of insulin signaling and GLUT4 translocation independent of IRS phosphorylation 54 Results 55 Primary kinase screen 55 Secondary screen 60 Tertiary screen 66 Discussion 75 Kinases known to function in insulin signaling and GLUT4 translocation 75 Kinases that interact with regulators of insulin signaling 77 Kinases related to ERK and JNK signaling 79 Kinases involved in regulation of trafficking 79 Metabolic proteins 80 Miscellaneous 81 Conclusion 81 Chapter 5 – Identifying DUB or ULP regulators of insulin signaling and GLUT4 translocation by siRNA screening 83 Introduction 84 Ubiquitin and Ubiquitin-like proteins 84 Ubiquitin system functions 85 Ubiquitin-like proteins and insulin signaling 87 Results 90 Primary screen 90 Secondary screen 96 Tertiary screen 100 Discussion 106 Proteins regulating protein stability and degradation 106 Proteins involved in mRNA processing and protein translation 107 Proteins involved in vesicle trafficking 109 Miscellaneous functions 109 Conclusion 110 Chapter 6 – General Discussion 112 Development and optimization of the HA-GLUT4-HeLa cell line 113 Involvement of the ERK/MAPK pathway in insulin signaling
Recommended publications
  • Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB
    Table S1. Kinase clones included in human kinase cDNA library for yeast two-hybrid screening Gene Symbol Gene Description ACVR1B activin A receptor, type IB ADCK2 aarF domain containing kinase 2 ADCK4 aarF domain containing kinase 4 AGK multiple substrate lipid kinase;MULK AK1 adenylate kinase 1 AK3 adenylate kinase 3 like 1 AK3L1 adenylate kinase 3 ALDH18A1 aldehyde dehydrogenase 18 family, member A1;ALDH18A1 ALK anaplastic lymphoma kinase (Ki-1) ALPK1 alpha-kinase 1 ALPK2 alpha-kinase 2 AMHR2 anti-Mullerian hormone receptor, type II ARAF v-raf murine sarcoma 3611 viral oncogene homolog 1 ARSG arylsulfatase G;ARSG AURKB aurora kinase B AURKC aurora kinase C BCKDK branched chain alpha-ketoacid dehydrogenase kinase BMPR1A bone morphogenetic protein receptor, type IA BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) BRAF v-raf murine sarcoma viral oncogene homolog B1 BRD3 bromodomain containing 3 BRD4 bromodomain containing 4 BTK Bruton agammaglobulinemia tyrosine kinase BUB1 BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) BUB1B BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) C9orf98 chromosome 9 open reading frame 98;C9orf98 CABC1 chaperone, ABC1 activity of bc1 complex like (S. pombe) CALM1 calmodulin 1 (phosphorylase kinase, delta) CALM2 calmodulin 2 (phosphorylase kinase, delta) CALM3 calmodulin 3 (phosphorylase kinase, delta) CAMK1 calcium/calmodulin-dependent protein kinase I CAMK2A calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha CAMK2B calcium/calmodulin-dependent
    [Show full text]
  • Mir-338-3P Functions As a Tumor Suppressor in Gastric Cancer by Targeting PTP1B
    Sun et al. Cell Death and Disease DOI 10.1038/s41419-018-0611-0 Cell Death & Disease ARTICLE Open Access miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B Feng Sun1, Mengchao Yu2,JingYu2, Zhijian Liu1,XinyanZhou2,YanqingLiu2, Xiaolong Ge3,HaidongGao2, Mei Li4, Xiaohong Jiang2,SongLiu1,XiChen2 and Wenxian Guan 1 Abstract Gastric cancer (GC) is one of the most common malignant tumors and peritoneal metastasis is the primary cause for advanced GC’s mortality. Protein-tyrosine phosphatase 1B (PTP1B) functions as an oncogene and involves in carcinogenesis and cancer dissemination. However, the function and regulation of PTP1B in GC remain poorly understood. In this study, we found that PTP1B was upregulated in GC tissues and overexpression of PTP1B in vitro promoted cell migration and prevented apoptosis. Then, we predicted that PTP1B was a target of miR-338-3p and we revealed an inverse correlation between miR-338-3p levels and PTP1B protein levels in GC tissues. Next, we verified that PTP1B was inhibited by miR-338-3p via direct targeting to its 3′-untranslated regions. Moreover, overexpression of miR-338-3p in vitro attenuated GC cell migration and promoted apoptosis, and these effects could be partially reversed by reintroduction of PTP1B. Finally, we established an orthotopic xenograft model and a peritoneal dissemination model of GC to demonstrate that miR-338-3p restrained tumor growth and dissemination in vivo by targeting PTP1B. Taken together, our results highlight that PTP1B is an oncogene and is negatively regulated by miR- 1234567890():,; 1234567890():,; 338-3p in GC, which may provide new insights into novel molecular therapeutic targets for GC.
    [Show full text]
  • Supporting Online Material
    1 2 3 4 5 6 7 Supplementary Information for 8 9 Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic 10 retinopathy 11 12 *Samuel A. Mills, *Andrew I. Jobling, *Michael A. Dixon, Bang V. Bui, Kirstan A. Vessey, Joanna A. Phipps, 13 Ursula Greferath, Gene Venables, Vickie H.Y. Wong, Connie H.Y. Wong, Zheng He, Flora Hui, James C. 14 Young, Josh Tonc, Elena Ivanova, Botir T. Sagdullaev, Erica L. Fletcher 15 * Joint first authors 16 17 Corresponding author: 18 Prof. Erica L. Fletcher. Department of Anatomy & Neuroscience. The University of Melbourne, Grattan St, 19 Parkville 3010, Victoria, Australia. 20 Email: [email protected] ; Tel: +61-3-8344-3218; Fax: +61-3-9347-5219 21 22 This PDF file includes: 23 24 Supplementary text 25 Figures S1 to S10 26 Tables S1 to S7 27 Legends for Movies S1 to S2 28 SI References 29 30 Other supplementary materials for this manuscript include the following: 31 32 Movies S1 to S2 33 34 35 36 1 1 Supplementary Information Text 2 Materials and Methods 3 Microglial process movement on retinal vessels 4 Dark agouti rats were anaesthetized, injected intraperitoneally with rhodamine B (Sigma-Aldrich) to label blood 5 vessels and retinal explants established as described in the main text. Retinal microglia were labelled with Iba-1 6 and imaging performed on an inverted confocal microscope (Leica SP5). Baseline images were taken for 10 7 minutes, followed by the addition of PBS (10 minutes) and then either fractalkine or fractalkine + candesartan 8 (10 minutes) using concentrations outlined in the main text.
    [Show full text]
  • Thesis FINAL
    The Role of CD1d-Mediated Lipid Presentation by Regulatory B Cells in Invariant Natural Killer T Cell Suppression of Autoimmunity by Kristine Oleinika Supervisor Professor Claudia Mauri UCL Immunology I, Kristine Oleinika, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. Kristine Oleinika Acknowledgements To Professor Claudia Mauri, my supervisor and mentor Throughout my PhD years I have so admired your energy and passion, which has made me fall in love with science over and over again. Thank you for looking after me, your guidance has been invaluable in my journey in both science and life. I am incredibly grateful for being part of the wonderful team that you have gathered around you, scientific debate that you have fostered in the group, and for encouraging the friendships within it. To all my colleagues You have made this such an adventure, sharing my enthusiasm for science, politics and footwear, with you I have always felt like a member of an incredibly, almost insultingly, over-educated and over-loving family. And I apologise for the many times you have had to endure listening to my idea for “PhD: the musical” and late night immunology aphorisms, or being on the receiving end of the impromptu enforced hugs. Lizzy, Diego and Paul – thank you for making me think about immunology, socialism, feminism, literature and art (..) ad infinitum. And for your helpful comments on the thesis. Madhvi, overachieving mama bear, thanks for being a fantastic listener.
    [Show full text]
  • Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) Through Multikinase Inhibition Jessica D
    Published OnlineFirst February 9, 2018; DOI: 10.1158/1078-0432.CCR-17-1928 Cancer Therapy: Preclinical Clinical Cancer Research Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition Jessica D. Lang1,William P.D. Hendricks1, Krystal A. Orlando2, Hongwei Yin1, Jeffrey Kiefer1, Pilar Ramos1, Ritin Sharma3, Patrick Pirrotte3, Elizabeth A. Raupach1,3, Chris Sereduk1, Nanyun Tang1, Winnie S. Liang1, Megan Washington1, Salvatore J. Facista1, Victoria L. Zismann1, Emily M. Cousins4, Michael B. Major4, Yemin Wang5, Anthony N. Karnezis5, Aleksandar Sekulic1,6, Ralf Hass7, Barbara C. Vanderhyden8, Praveen Nair9, Bernard E. Weissman2, David G. Huntsman5,10, and Jeffrey M. Trent1 Abstract Purpose: Small cell carcinoma of the ovary, hypercalcemic type three SWI/SNF wild-type ovarian cancer cell lines. We further (SCCOHT) is a rare, aggressive ovarian cancer in young women identified ponatinib as the most effective clinically approved that is universally driven by loss of the SWI/SNF ATPase subunits RTK inhibitor. Reexpression of SMARCA4 was shown to confer SMARCA4 and SMARCA2. A great need exists for effective targeted a 1.7-fold increase in resistance to ponatinib. Subsequent therapies for SCCOHT. proteomic assessment of ponatinib target modulation in Experimental Design: To identify underlying therapeutic vul- SCCOHT cell models confirmed inhibition of nine known nerabilities in SCCOHT, we conducted high-throughput siRNA ponatinib target kinases alongside 77 noncanonical ponatinib and drug screens. Complementary proteomics approaches pro- targets in SCCOHT. Finally, ponatinib delayed tumor dou- filed kinases inhibited by ponatinib. Ponatinib was tested for bling time 4-fold in SCCOHT-1 xenografts while reducing efficacy in two patient-derived xenograft (PDX) models and one final tumor volumes in SCCOHT PDX models by 58.6% and cell-line xenograft model of SCCOHT.
    [Show full text]
  • Hyperactive and Impulsive Behaviors of LMTK1 Knockout Mice
    www.nature.com/scientificreports OPEN Hyperactive and impulsive behaviors of LMTK1 knockout mice Miyuki Takahashi1,7, Arika Sugiyama1, Ran Wei1, Shizuka Kobayashi2, Kimiko Fukuda3, Hironori Nishino1, Roka Takahashi1, Koji Tsutsumi1,8, Ichiro Kita4, Kanae Ando1, Toshiya Manabe2, Hiroyuki Kamiguchi5, Mineko Tomomura6 & Shin‑ichi Hisanaga1* Lemur tail kinase 1 (LMTK1), previously called Apoptosis‑Associated Tyrosine Kinase (AATYK), remains an uncharacterized Ser/Thr protein kinase that is predominantly expressed in the brain. It is recently reported that LMTK1A, an isoform of LMTK1, binds to recycling endosomes through its palmitoylation and regulates endosomal trafcking by suppressing the activity of Rab11 small GTPase. In neurons, knockdown or knockout of LMTK1 results in longer axons, greater branching of dendrites and increased number of spines, suggesting that LMTK1 plays a role in neuronal circuit formation. However, its in vivo function remained to be investigated. Here, we examined the brain structures and behaviors of LMTK1 knockout (KO) mice. LMTK1 was expressed in most neurons throughout the brain. The overall brain structure appeared to be normal in LMTK1 KO mice, but the numbers of synapses were increased. LMTK1 KO mice had a slight impairment in memory formation and exhibited distinct psychiatric behaviors such as hyperactivity, impulsiveness and high motor coordination without social interaction defcits. Some of these abnormal behaviors represent core features of attention defcit hyperactive disorder (ADHD), suggesting the possible involvement of LMTK1 in the pathogenesis of ADHD. Abbreviations AATYK1 Apoptosis-Associated Tyrosine Kinase ADHD Attention defcit hyperactive disorder Cx Cerebral cortex Cb Cerebellum CS Conditioned stimulus ISH In situ hybridization KO Knockout LMTK Lemur tail kinase PPF Paired-pulse facilitation US Unconditioned stimulus WT Wildtype Neuronal circuit wiring is the structural and functional basis of higher brain activities such as recognition and behaviors.
    [Show full text]
  • Angiopoietin 4 (ANGPT4) (NM 015985) Human Untagged Clone Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for SC304373 Angiopoietin 4 (ANGPT4) (NM_015985) Human Untagged Clone Product data: Product Type: Expression Plasmids Product Name: Angiopoietin 4 (ANGPT4) (NM_015985) Human Untagged Clone Tag: Tag Free Symbol: ANGPT4 Synonyms: ANG3; ANG4 Vector: pCMV6-XL5 E. coli Selection: Ampicillin (100 ug/mL) Cell Selection: None This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 3 Angiopoietin 4 (ANGPT4) (NM_015985) Human Untagged Clone – SC304373 Fully Sequenced ORF: >OriGene sequence for NM_015985 edited CAGGCAAGCCTGGCCACTGTTGGCTGCAGCAGGACATCCCAGGCACAGCCCCTAGGGCTC TGAGCAGACATCCCTCGCCATTGACACATCTTCAGATGCTCTCCCAGCTAGCCATGCTGC AGGGCAGCCTCCTCCTTGTGGTTGCCACCATGTCTGTGGCTCAACAGACAAGGCAGGAGG CGGATAGGGGCTGCGAGACACTTGTAGTCCAGCACGGCCACTGTAGCTACACCTTCTTGC TGCCCAAGTCTGAGCCCTGCCCTCCGGGGCCTGAGGTCTCCAGGGACTCCAACACCCTCC AGAGAGAATCACTGGCCAACCCACTGCACCTGGGGAAGTTGCCCACCCAGCAGGTGAAAC AGCTGGAGCAGGCACTGCAGAACAACACGCAGTGGCTGAAGAAGCTAGAGAGGGCCATCA AGACGATCTTGAGGTCGAAGCTGGAGCAGGTCCAGCAGCAAATGGCCCAGAATCAGACGG CCCCCATGCTAGAGCTGGGCACCAGCCTCCTGAACCAGACCACTGCCCAGATCCGCAAGC TGACCGACATGGAGGCTCAGCTCCTGAACCAGACATCAAGAATGGATGCCCAGATGCCAG AGACCTTTCTGTCCACCAACAAGCTGGAGAACCAGCTGCTGCTACAGAGGCAGAAGCTCC AGCAGCTTCAGGGCCAAAACAGCGCGCTCGAGAAGCGGTTGCAGGCCCTGGAGACCAAGC
    [Show full text]
  • Effect of STAT3 Inhibition on the Metabolic Switch in a Highly STAT3-Activated Lymphoma Cell Line
    CANCER GENOMICS & PROTEOMICS 12 : 133-142 (2015) Effect of STAT3 Inhibition on the Metabolic Switch in a Highly STAT3-activated Lymphoma Cell Line YASUTO AKIYAMA 1* , AKIRA IIZUKA 1* , AKIKO KUME 1, MASARU KOMIYAMA 1, KENICHI URAKAMI 2, TADASHI ASHIZAWA 1, HARUO MIYATA 1, MAHO OMIYA 1, MASATOSHI KUSUHARA 3 and KEN YAMAGUCHI 4 1Immunotherapy Division, 2Cancer Diagnostics Division, 3Regional Resources Division, Shizuoka Cancer Center Research Institute, Sunto-gun, Shizuoka, Japan; 4Office of the President, Shizuoka Cancer Center Hospital, Sunto-gun, Shizuoka, Japan Abstract. Background: Signal transducer and activator of enzymes including fructose-bisphosphate aldolase A transcription (STAT)3 is involved in a metabolic shift in (ALDOA) as a metabolic marker candidate for STAT3- cancer cells, the Warburg effect through its pro-oncogenic targeting therapy using STAT3-specific shRNA gene activity. To develop efficient STAT3 inhibitors against cancer transduction. In particular, latexin expression was up- cells, novel proteomic and metabolic target molecules need regulated in four STAT3-activated cancer cell lines including to be explored using multi-omics approaches in the context of SCC-3 transduced with STAT3-specific shRNA. The up- STAT3 gene inhibition-mediated tumor growth suppression. regulation of latexin was identified in SCC-3 tumors Materials and Methods: We found that short hairpin transplanted to nude mice after treatment with STAT3 (sh)RNA-mediated STAT3 inhibition suppressed tumor inhibitor. Conclusion: Our results suggest that STAT3 growth in a highly STAT3-activated lymphoma cell line, inactivation reverses the glycolytic shift by down-regulating SCC-3 cells, and we investigated the effect of STAT3 key enzymes and that it induces up-regulation of latexin as a inhibition on metabolic switching using 2-dimensional tumor-suppressor molecule, which partially results in cancer differential gel electrophoresis and capillary electrophoresis- cell apoptosis and tumor growth suppression.
    [Show full text]
  • Mtor Regulation of Metabolism in Hematologic Malignancies
    cells Review mTOR Regulation of Metabolism in Hematologic Malignancies Simone Mirabilii 1 , Maria Rosaria Ricciardi 1 and Agostino Tafuri 1,2,* 1 Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy; [email protected] (S.M.); [email protected] (M.R.R.) 2 Hematology, “Sant’ Andrea” University Hospital, Sapienza University of Rome, 00185 Rome, Italy * Correspondence: [email protected]; Tel.: +39-06-3377-5113 Received: 6 December 2019; Accepted: 7 February 2020; Published: 11 February 2020 Abstract: Neoplastic cells rewire their metabolism, acquiring a selective advantage over normal cells and a protection from therapeutic agents. The mammalian Target of Rapamycin (mTOR) is a serine/threonine kinase involved in a variety of cellular activities, including the control of metabolic processes. mTOR is hyperactivated in a large number of tumor types, and among them, in many hematologic malignancies. In this article, we summarized the evidence from the literature that describes a central role for mTOR in the acquisition of new metabolic phenotypes for different hematologic malignancies, in concert with other metabolic modulators (AMPK, HIF1α) and microenvironmental stimuli, and shows how these features can be targeted for therapeutic purposes. Keywords: mTOR; hematologic malignancies; cell metabolism 1. mTOR Structure and Function The mammalian Target of Rapamycin (mTOR) is a kinase involved in the PI3k/PTEN/Akt axis, which plays a key role in the control of many biological processes, including cell growth and survival, protein translation, ribosomal biogenesis, autophagy, and metabolism [1–3]. Originally identified in the yeast Saccharomyces cerevisiae, mTOR is a pleiotropic serine/threonine kinase of 289kDa, which shows a terminal COOH catalytic domain with a high sequence homology with PI3K [4].
    [Show full text]
  • 1714 Gene Comprehensive Cancer Panel Enriched for Clinically Actionable Genes with Additional Biologically Relevant Genes 400-500X Average Coverage on Tumor
    xO GENE PANEL 1714 gene comprehensive cancer panel enriched for clinically actionable genes with additional biologically relevant genes 400-500x average coverage on tumor Genes A-C Genes D-F Genes G-I Genes J-L AATK ATAD2B BTG1 CDH7 CREM DACH1 EPHA1 FES G6PC3 HGF IL18RAP JADE1 LMO1 ABCA1 ATF1 BTG2 CDK1 CRHR1 DACH2 EPHA2 FEV G6PD HIF1A IL1R1 JAK1 LMO2 ABCB1 ATM BTG3 CDK10 CRK DAXX EPHA3 FGF1 GAB1 HIF1AN IL1R2 JAK2 LMO7 ABCB11 ATR BTK CDK11A CRKL DBH EPHA4 FGF10 GAB2 HIST1H1E IL1RAP JAK3 LMTK2 ABCB4 ATRX BTRC CDK11B CRLF2 DCC EPHA5 FGF11 GABPA HIST1H3B IL20RA JARID2 LMTK3 ABCC1 AURKA BUB1 CDK12 CRTC1 DCUN1D1 EPHA6 FGF12 GALNT12 HIST1H4E IL20RB JAZF1 LPHN2 ABCC2 AURKB BUB1B CDK13 CRTC2 DCUN1D2 EPHA7 FGF13 GATA1 HLA-A IL21R JMJD1C LPHN3 ABCG1 AURKC BUB3 CDK14 CRTC3 DDB2 EPHA8 FGF14 GATA2 HLA-B IL22RA1 JMJD4 LPP ABCG2 AXIN1 C11orf30 CDK15 CSF1 DDIT3 EPHB1 FGF16 GATA3 HLF IL22RA2 JMJD6 LRP1B ABI1 AXIN2 CACNA1C CDK16 CSF1R DDR1 EPHB2 FGF17 GATA5 HLTF IL23R JMJD7 LRP5 ABL1 AXL CACNA1S CDK17 CSF2RA DDR2 EPHB3 FGF18 GATA6 HMGA1 IL2RA JMJD8 LRP6 ABL2 B2M CACNB2 CDK18 CSF2RB DDX3X EPHB4 FGF19 GDNF HMGA2 IL2RB JUN LRRK2 ACE BABAM1 CADM2 CDK19 CSF3R DDX5 EPHB6 FGF2 GFI1 HMGCR IL2RG JUNB LSM1 ACSL6 BACH1 CALR CDK2 CSK DDX6 EPOR FGF20 GFI1B HNF1A IL3 JUND LTK ACTA2 BACH2 CAMTA1 CDK20 CSNK1D DEK ERBB2 FGF21 GFRA4 HNF1B IL3RA JUP LYL1 ACTC1 BAG4 CAPRIN2 CDK3 CSNK1E DHFR ERBB3 FGF22 GGCX HNRNPA3 IL4R KAT2A LYN ACVR1 BAI3 CARD10 CDK4 CTCF DHH ERBB4 FGF23 GHR HOXA10 IL5RA KAT2B LZTR1 ACVR1B BAP1 CARD11 CDK5 CTCFL DIAPH1 ERCC1 FGF3 GID4 HOXA11 IL6R KAT5 ACVR2A
    [Show full text]
  • Metabolic Plasticity Is an Essential Requirement of Acquired Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia
    cancers Article Metabolic Plasticity Is an Essential Requirement of Acquired Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia Miriam G. Contreras Mostazo 1,2,3, Nina Kurrle 3,4,5, Marta Casado 6,7 , Dominik Fuhrmann 8, Islam Alshamleh 4,9, Björn Häupl 3,4,5, Paloma Martín-Sanz 7,10, Bernhard Brüne 5,8,11 , 3,4,5 4,9 3,4,5, 1,2,7,12, , Hubert Serve , Harald Schwalbe , Frank Schnütgen y , Silvia Marin * y 1,2,7,12, , and Marta Cascante * y 1 Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona, 08028 Barcelona, Spain; [email protected] 2 Institute of Biomedicine of University of Barcelona, 08028 Barcelona, Spain 3 Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe-University, 60590 Frankfurt am Main, Germany; [email protected] (N.K.); [email protected] (B.H.); [email protected] (H.S.); [email protected] (F.S.) 4 German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; [email protected] (I.A.); [email protected] (H.S.) 5 Frankfurt Cancer Institute (FCI), Goethe University, 60590 Frankfurt am Main, Germany; [email protected] 6 Biomedicine Institute of Valencia, IBV-CSIC, 46010 Valencia, Spain; [email protected] 7 CIBER of Hepatic and Digestive Diseases (CIBEREHD), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain; [email protected] 8 Institute of Biochemistry I, Faculty of
    [Show full text]
  • The Role of Overexpressed Apolipoprotein AV in Insulin-Resistant Hepatocytes
    Hindawi BioMed Research International Volume 2020, Article ID 3268505, 13 pages https://doi.org/10.1155/2020/3268505 Research Article The Role of Overexpressed Apolipoprotein AV in Insulin-Resistant Hepatocytes Wang Zhao,1 Yaqiong Liu,1 Xiaobo Liao,2 and Shuiping Zhao 1 1Department of Cardiovascular Medicine, e Second Xiangya Hospital, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, China 2Department of Cardiovascular Surgery, e Second Xiangya Hospital, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, China Correspondence should be addressed to Shuiping Zhao; [email protected] Received 31 January 2019; Revised 16 July 2019; Accepted 16 August 2019; Published 21 April 2020 Academic Editor: Kui Li Copyright © 2020 Wang Zhao et al. *is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In this paper, we sought to explore the relationship between apolipoprotein AV (APOAV) overexpression and insulin resistance in hepatocytes. *e insulin-resistant HepG2 cell model was constructed, and then, APOAV-overexpressed HepG2 cells (B-M) were induced by infecting with a recombinant adenovirus vector. Microarray data were developed from B-M samples compared with negative controls (A-con), and the microarray data were analyzed by bioinformatic methods. APOAV-overexpression induced 313 upregulated genes and 563 downregulated ones in B-M sample. *e differentially expressed genes (DEGs) were significantly classified in fat digestion and absorption pathway. Protein-protein interaction network was constructed, and AGTR1 (angiotensin II receptor type 1) and P2RY2 (purinergic receptor P2Y, G-protein coupled 2) were found to be the significant nodes closely related with G-protein related signaling.
    [Show full text]